Catapult Ventures

Founded 1999
Founders Darren Liccardo Rouz Jazayeri


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 83
Average round size
The average size of a deal this fund participated in
Portfolio companies 67
Rounds per year 3.77
Lead investments 15
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 23
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Pharmaceutical

Catapult Ventures appeared to be the VC, which was created in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Leicester.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Catapult Ventures, startups are often financed by South East Growth Fund & Management, Oxford Capital Partners, Spark Ventures. The meaningful sponsors for the fund in investment in the same round are Midven, Spark Ventures, South East Growth Fund & Management. In the next rounds fund is usually obtained by South East Growth Fund & Management, Oxford Capital Partners, Octopus Ventures.

Besides them, we counted 2 critical employees of this fund in our database.

Among the most successful fund investment fields, there are Pharmaceutical, Clinical Trials. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the various public portfolio startups of the fund, we may underline Abzena plc, AMR Centre, MicroBioSensor

Speaking about the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The top activity for fund was in 2008. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2017. Opposing the other organizations, this Catapult Ventures works on 0 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year.

Read more

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation


Medical Device
$363K29 Apr 2021 United Kingdom, " United Kingdom"}


Health Care
$4M08 Apr 2021 United Kingdom, " United Kingdom"}

Left Hand Robotics

Machinery Manufacturing
$3M29 Aug 2019 United States, " United States"}

Advanced Farm Technologies

$7M27 Aug 2019 United States, " United States"}

Business Information Systems
Enterprise Applications
Health Care
16 Aug 2018 United Kingdom, Lancaster


Health Care
Health Diagnostics
Life Science
Medical Device
$316K27 Mar 2018 United Kingdom, Manchester

Acea Health

Health Care
24 Jan 2018 United Kingdom, Manchester


Health Diagnostics
Medical Device
$1M16 Nov 2017 United Kingdom, Manchester

Elucid mHealth

Clinical Trials
Data Integration
Health Care
$1M19 Sep 2017 United Kingdom, Manchester
Oculii Raises $55M in Series B Funding

– Oculii, a maker of high-resolution commercial imaging 4D radar, raised $55M in Series B funding.
– The round was co-led by Catapult Ventures and Conductive Ventures, with participation from Taiwania Capital, Susquehanna Investment Group (SIG), HELLA Ventures, PHI-Zoyi Capital, R7 Partners, VectoIQ, ACVC Partners, Mesh Ventures, SV Tech Ventures, Schox Ventures, and Signature Bank.
– The new funding will be used to scale and deliver on demand of Tier-1’s and OEMs globally.

Maxwellia Raises £3.2M in Funding

– Maxwellia is an Alderley Park, UK-based self-care company.
– The company raised £3.2m in funding led by Praetura Ventures with participation from the Future Fund, Catapult Ventures, Alderley Park Ventures and Biocity along with individual and angel investors.
– The new investment will be used to scale up the manufacture and rollout of drugs following MHRA approval.
– Maxwellia’s chief executive Anna Maxwell is a pharmacist with over 20 years’ experience.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Catapult Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: